Endothelin signaling in diabetic kidney disease: therapeutic targeting and translational advances
Diabetic kidney disease (DKD) is the most prevalent microvascular complication of type 2 diabetes mellitus (T2DM) and a leading global cause of end-stage kidney disease (ESKD). Current first-line regimens, including renin-angiotensin-aldosterone system inhibitors and sodium-glucose cotransporter 2 inhibitors, only part...